Patients with Frozen-Phase Frozen Shoulder Demonstrated Improvement of Pain and Mobility of Forward Elevation and Internal Rotation After a Single Glenohumeral Injection of Corticosteroids

Q3 Medicine

Arthroscopy Sports Medicine and Rehabilitation Pub Date : 2025-02-01 DOI:10.1016/j.asmr.2024.101025

Wei-Hsuan Wang , Poyu Chen Ph.D. , Louis Yi Lu M.D. , Cheng-Pang Yang M.D. , Joe Chih-Hao Chiu M.D., Ph.D.

{"title":"Patients with Frozen-Phase Frozen Shoulder Demonstrated Improvement of Pain and Mobility of Forward Elevation and Internal Rotation After a Single Glenohumeral Injection of Corticosteroids","authors":"Wei-Hsuan Wang , Poyu Chen Ph.D. , Louis Yi Lu M.D. , Cheng-Pang Yang M.D. , Joe Chih-Hao Chiu M.D., Ph.D.","doi":"10.1016/j.asmr.2024.101025","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>To investigate the improvement in frozen-phase frozen shoulder (FS) patients’ pain and shoulder mobility, including passive forward elevation (FE), external rotation (ER), and internal rotation (IR), after 2 consecutive intra-articular corticosteroid (IACS) injections.</div></div><div><h3>Methods</h3><div>This retrospective cohort study was performed from July 2020 to November 2023. All patients with frozen-phase FS received 2 ultrasound-guided IACS injections at 6-week intervals. FE, ER, IR, and visual analog scale scores were measured at each follow-up consultation with a 6-week interval.</div></div><div><h3>Results</h3><div>A total of 134 patients finished the study. There were varying degrees of change in pain relief and range-of-motion improvement between each IACS injection. FE and IR improved significantly between the first and second injections (<em>P</em> = 5.2 × 10<sup>−</sup><sup>24</sup> and 1.1 × 10<sup>−</sup><sup>21</sup>, respectively), whereas ER only improved significantly after the second injection (<em>P</em> < .05). The pain level improved both after the first injection and after the second injection (both <em>p</em> < .001).</div></div><div><h3>Conclusions</h3><div>Patients with frozen-phase FS show improved pain, FE mobility, and IR mobility after a single IACS injection. However, a second IACS injection provides similar therapeutic effects and significantly improves ER mobility.</div></div><div><h3>Level of Evidence</h3><div>Level III, retrospective cohort study.</div></div>","PeriodicalId":34631,"journal":{"name":"Arthroscopy Sports Medicine and Rehabilitation","volume":"7 1","pages":"Article 101025"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arthroscopy Sports Medicine and Rehabilitation","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666061X24001688","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose

To investigate the improvement in frozen-phase frozen shoulder (FS) patients’ pain and shoulder mobility, including passive forward elevation (FE), external rotation (ER), and internal rotation (IR), after 2 consecutive intra-articular corticosteroid (IACS) injections.

Methods

This retrospective cohort study was performed from July 2020 to November 2023. All patients with frozen-phase FS received 2 ultrasound-guided IACS injections at 6-week intervals. FE, ER, IR, and visual analog scale scores were measured at each follow-up consultation with a 6-week interval.

Results

A total of 134 patients finished the study. There were varying degrees of change in pain relief and range-of-motion improvement between each IACS injection. FE and IR improved significantly between the first and second injections (P = 5.2 × 10⁻²⁴ and 1.1 × 10⁻²¹, respectively), whereas ER only improved significantly after the second injection (P < .05). The pain level improved both after the first injection and after the second injection (both p < .001).

Conclusions

Patients with frozen-phase FS show improved pain, FE mobility, and IR mobility after a single IACS injection. However, a second IACS injection provides similar therapeutic effects and significantly improves ER mobility.